Why It Matters
Georgia residents and millions of Americans across the country may be drinking water that contains microplastics and pharmaceutical compounds, according to new guidance from the U.S. Environmental Protection Agency. The EPA’s formal identification of these substances as contaminants of concern marks a significant regulatory step that could reshape how states — including Georgia — treat, monitor, and report on public drinking water supplies.
Water quality and public health officials warn that the long-term health implications of consuming microplastics and trace pharmaceuticals remain an active area of scientific research, making the EPA’s regulatory attention increasingly urgent. For Georgia households already navigating rising healthcare costs, any expansion of water-related illness or treatment could place additional financial pressure on families statewide.
What Happened
The EPA has formally flagged microplastics and pharmaceutical compounds as emerging contaminants in the nation’s drinking water systems. The agency’s action signals growing federal concern over substances that current standard water treatment infrastructure was not originally designed to filter or eliminate.
Microplastics — tiny plastic particles measuring less than five millimeters — enter water supplies through a range of sources, including degraded plastic waste, synthetic clothing fibers, and industrial runoff. Pharmaceuticals, including hormones, antibiotics, and pain medications, enter water systems primarily through human excretion and improper medication disposal, passing through wastewater treatment plants that are not fully equipped to remove them.
Georgia’s water systems, like those in most U.S. states, rely on treatment technologies developed decades ago. The EPA’s updated guidance puts pressure on state environmental and public health agencies to assess whether current infrastructure is adequate to address these newly identified contaminants.
By the Numbers
Over 300 million Americans rely on public drinking water systems regulated under the Safe Drinking Water Act, the federal law that governs contaminant standards the EPA enforces.
More than 80,000 chemical substances are currently registered for use in the United States, yet only a fraction are regulated under existing federal drinking water standards — a gap that has drawn criticism from environmental health advocates for years.
Approximately 94% of water samples tested in a widely cited U.S. Geological Survey study were found to contain microplastic particles, highlighting the near-ubiquitous presence of these substances in water sources nationwide.
At least 56 different pharmaceutical compounds have been detected in U.S. water supplies, according to federal and academic research compiled over the past two decades.
Georgia operates more than 4,000 public water systems serving communities ranging from metropolitan Atlanta to rural counties, all of which could be subject to updated compliance requirements as EPA regulations evolve.
Zoom Out
The EPA’s action reflects a broader national and global reckoning with so-called “contaminants of emerging concern” — substances that science has identified as potentially harmful but that lack comprehensive regulatory frameworks. The Biden administration began expanding attention to per- and polyfluoroalkyl substances (PFAS), commonly called “forever chemicals,” and the current Trump administration has continued federal scrutiny of drinking water quality as a public health priority.
Several states, including California, Minnesota, and New York, have moved ahead of federal action to establish their own monitoring and reporting requirements for microplastics in drinking water. Georgia has not yet enacted state-level microplastics standards, leaving the question of regulatory response largely tied to federal EPA timelines.
The issue also intersects with ongoing debates over pharmaceutical access and regulation. In Georgia, conversations around drug safety and over-the-counter availability — including discussions about medications like ivermectin being made available without a prescription — highlight the broader complexity of how pharmaceuticals move through communities and, ultimately, through water systems.
What’s Next
The EPA is expected to move toward formal rulemaking that could establish maximum contaminant levels (MCLs) for microplastics and select pharmaceutical compounds. That process typically involves public comment periods, scientific review panels, and cost-benefit analysis before any final rule takes effect.
Georgia environmental agencies, including the Georgia Environmental Protection Division, will likely be required to update monitoring protocols and potentially expand testing requirements for public water utilities once federal standards are finalized.
Water system operators and municipal governments across Georgia should anticipate guidance in the coming months on updated testing procedures, infrastructure assessment requirements, and potential funding opportunities tied to the federal Infrastructure Investment and Jobs Act, which allocated billions toward water system upgrades nationwide.
Public comment opportunities are expected to be announced as the EPA advances its regulatory review process.